Quality of life, satisfaction and therapeutic adherence in atopic dermatitis;Calidad de vida, satisfacción y adherencia terapéutica en dermatitis atópica

Pediatrika

Volumn 27, Issue 3, 2007, Pages 31-40

  Polanco Allue I ^a   Gonzalez Hachero J ^b   Rodrigo Gonzalo De Liria, C ^c   Garcia Diez A ^d   Garcia Patos Briones V ^e   Zambrano Zambrano, A ^f  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Atopic dermatitis; Caregivers; Patient satisfaction; Quality of life

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; CAREGIVER; CHILD; CLOTHING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SPAIN; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 34248526021     PISSN: 02113465     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Paller AS, Mc Alister RO, Doyle JJ, Jackson A. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact and its treatment. Clin Pediatr (Phila) 2002;41:323-32.
2. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:291-6.
3. Long CC, Funenell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want? Clin Exp Dermatol 1993;18:516-22.
4. Logan RA. Self help groups for patients with chronic skin diseases. Br J Dermatol 1988;118:505-8.
5. Puli- Pott U, Darui A, Beckman D. Infants with atopic dermatitis: maternal hopelessness, child-rearin attitudes and preceived infant temperament. Psychother Psychosom 1999;68:39-45.
6. Finlay AY, Khan GK. Dermatology Life quality Index (DLQI): a simple practical measure for routine clinica use. Clin Exp Dermatol 1994;19:210-6.
7. Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Y, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001;44:S65-72.
8. Lewis-Jones MS, Finlay QY. The Children's Dermatology Life Quality Index (CDLQI) : initial validation and practical use. Br J Dermatol 1995;132:942-9.
9. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998;138:107-13.
10. McKenna SP, Whalley D, Dewar AL, Erdman RAM, Kohlmann T, Niero M, et al. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005;14:231-41.
11. Badia X, Carné X. La evaluación de la calidad de vida en los ensayos clínicos. Med Clin (Barc) 1998;110:550-6.
12. Herdman M, Badia X. La medida de la satisfacción con el tratamiento en la investigación de Resultados en Salud. En: Investigación de Resultados en Salud. Barcelona: Edimac; 2000. p. 79-90
13. Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I. The dorzolamide/timolol combination versus timolol plus pilocarpine:patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. J Glaucoma 1999;8:315-24.
14. Shikiar R, Halpern M, McGann M, Palmer CS, Seidllin M. The relation of patient satisfaction with treatment of otitis externa to clinical outcomes:development of an instrument. Clin Ther 1999;21:1091-104.
15. Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001;117:852-85.
16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medications adherence. Med Care 1986; 24:67-74.
17. Seymour JL, Keswick BH, Hanifin JM, Jordan WP, Milligan MC. Clinical effects of diaper types on the skin of normal infants with atopic dermatitis. J Am Acad Dermatol 1987;17:988-97.
18. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EA-SI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001;10:11-8.
19. Del Pozo MD, Lobera T. Calidad de vida en Dermatología. Allergol Inmunol Clin 2001;16:245-9.
20. Eichenfield LF, Lucky AW, Boguniewicz M, Langley R, Cherill R, Marshall K, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495-504.
21. McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, et al. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel ®, SDZ ASM 981): impact on quality of life and health - related quality of life. JEDV 2006; 20: 0001-0007.
22. Badia Llach X, Lara N, Roset M. Quality of life, time commitment and burden perceived by the principal informal caregiver of Alzheimer's patients. Aten Primaria 2004;34:170-7.
23. Ben Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002;16:455-62.
24. Balkrishnan R, Manuel J, Clarke J, Carroll CL, Housman TS, Fleischer AB. Effects of an epidsode of specialist care on the impact of childhood atopic dermatitis on the child's family. J Pediatr Health Care 2003;17:184-9.
25. Carroll CL, Balkrishnan R, Feldman SR, Fleischer ABJr, Manuel JC. The burden of atopic dermatitis: impact on the patients, family and society. Pediatr Dermatol 2005;22:192-9.
26. Shikiar R, Halpern M, McGann M, Palmer CS, Seidlin M. The relation of patient satisfaction with treatment of otitis externa to clinical outcomes:development of an instrument. Clin Ther 1999; 21:1091-104.